Hepatocyte‐specific deletion of the antiapoptotic protein myeloid cell leukemia‐1 triggers proliferation and hepatocarcinogenesis in mice†
Achim Weber(University Hospital of Zurich), Henning Schulze‐Bergkamen(Heidelberg University), Toni Urbanik(Johannes Gutenberg University Mainz), Joseph T. Opferman(St. Jude Children's Research Hospital), Binje Vick(Helmholtz Zentrum München), Peter H. Krammer(Slovak Academy of Sciences), Peter R. Galle(Johannes Gutenberg University Mainz), Johannes Haybaeck(Medical University of Graz), Stefan Zoller, Andreas Teufel(Johannes Gutenberg University Mainz), Marcus Schuchmann(Klinikum Konstanz), Regina Boger(National Center for Tumor Diseases), Mathias Heikenwälder(University of Tübingen)
Cited by 121
Related Papers
FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex
|Cell|1996|3.1k
Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.
|The EMBO Journal|1995|2.2k
Death and anti-death: tumour resistance to apoptosis
|Nature reviews. Cancer|2002|2.1k
Simplified criteria for the diagnosis of autoimmune hepatitis†
|Hepatology|2008|1.9k
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
|Science|1989|1.7k